Pressmeddelande CB Health Access India

Swedish, Finnish and Estonian Companies Exploring India, One of the Fastest Growing Healthcare Markets in the World

Nine companies from Sweden, Finland and Estonia attended a business mission to India in September 2017 to meet with the healthcare actors in New Delhi and Bengaluru. The business visit was organized in cooperation with Innovatio Curis, and under the framework of CB Health Access, an international EU-funded program.

The participating companies attended the InnoHealth conference in New Delhi, an annual event dedicated to innovation in healthcare. In addition, a study trip to Bengaluru was held, to offer the companies a more in-depth view of the healthcare sector in India, as well as into the local regulations and business culture. Matchmaking sessions were held at both locations, to ensure that the companies would be exposed to as many potential partners as possible.   

The Indian healthcare market is full of opportunities for European health technology companies. According to Dr. Sweta Suresh of Swissnex India, “The total market worth was estimated at 81,3 billion USD in 2013, with a 17% CAGR.” Håkan Jidéus from the Swedish company Predicare found the design of the program very beneficial and that he received support beyond his expectations. Sohini Mandal from an Indian law firm NovoJuris added, “we want to explore the European side of business of these companies and if there are opportunities to get connected.”

The CB Health Access program was initiated in 2016 between Estonian, Finnish, Latvian and Swedish technology organizations to support entrepreneurship in health technologies. The program facilitates the entry of Estonian, Latvian, Swedish and Finnish health tech companies to distant markets – South Korea, USA, India and Uganda. CB Health Access provides the companies with an introduction of the target market, individual coaching both from the home country and from target market experts, market information, business missions, and identifying and contacting potential partners, and business missions. The program is financed by the Central Baltic Interreg Program.
For more information on the CB Health Access program see, or contact: malin.hollmark (at)